Home > Clinical Trials

Saved trials

RECRUITING
NCT06494111
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
295 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Lymphedema


Fibrosis
RECRUITING
NCT05491200
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
1,656 Enrollment(s)
26 Study location(s)
INTERVENTIONAL (PHASE4)
ST Elevated Myocardial Infarction


Dual Antiplatelet Therapy
COMPLETED
NCT04284657
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
1 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Autosomal Dominant Polycystic Kidney Disease
ACTIVE_NOT_RECRUITING
NCT03793478
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
65 Enrollment(s)
27 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia
RECRUITING
NCT06262438
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia in Children
NOT_YET_RECRUITING
NCT07098975
Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)
154 Enrollment(s)
2 Study location(s)
INTERVENTIONAL (PHASE2)
Preeclampsia (PE)


Intrauterine Growth Restriction (IUGR)


Placental Insufficiency
COMPLETED
NCT06772246
A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate
70 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Healthy Subjects
ACTIVE_NOT_RECRUITING
NCT04556773
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
138 Enrollment(s)
37 Study location(s)
INTERVENTIONAL (PHASE1)
Metastatic Breast Cancer